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Abstract  
 
Ampicillin and Norfloxacin are used to treat variety of bacterial infections. These two drugs have low 
oral bioavailability. Co-administration of Piperine (20mg/kg), an alkaloid from Piper nigrum L. enhanced oral 
bioavailability of Ampicillin and Norfloxacin in animal model. This is reflected in various pharmacokinetic 
measurements like Cmax, Tmax, AUC and t½ of the above antibiotics in animal model. 
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Introduction 
 
 Piperine(1-piperoyl piperdine) is a major component of the Piper species. This species has been used 
widely as spices and in various systems of Indian medicine (Atal et.al 1981). Piperine has various 
pharmacological activities namely anti-asthmatic along with Adhatoda vasaca (Wealth of India,1969), 
antifertility (Piyachaturwat et al., 1982), CNS depressant and anti-inflammatory(Lee et.al., 1984, Majumdar et 
al., 1990a, Dhuley et al., 1993), inhibition of hepatic monooxygenase and UDP-glucouronyl transferase and 
intestinal glucouronidation (Atal et.al 1981, Atal et.al 1985, Singh et.al 1986), inhibition of CYP3A4 and p-
glycoprotein  (PGP) (Bhardwaj et.al., 2002). In addition Piperine has also been shown to enhance the 
bioavailability of drugs like vascicine, sparteine, curcumin, barbiturate and oxyphenylbutazone, zoxazolamine, 
propranalol and theophylline in animal experiments (Atal et al., 1981, Majumdar et al., 1990a, Shobha et al 
.,1998, Majumdar et al., 1990b, Majumdar et al., 1999, Bano et al., 1991). Ampicillin and Norfloxacin are 
extensively used in various infections (Sweetman, 2002) and they exhibit low oral-bioavailability. The oral 
bioavailability oif Ampicillin is 62±17% and that of Norfloxacin is 30% to 40% ( Leslie et al.,1991,Sweetman, 
2002). The study was aimed to find out the effect of Piperine in enhancing oral bioavailability of Ampicillin and 
Norfloxacin in rabbits. 
 
Materials and Methods 
 
 Piperine sample was received from M/s Sami labs, Bangalore. The antibiotics (Ampicillin Trihydrate 
and Norfloxacin) were purchased from M/s MMC laboratories, Chennai and the samples were found to comply 
with specifications as per Indian Pharmacopoeia (Pharmacopoeia of India, 1996). The test microorganisms 
Micrococcus luteus (ATCC9341) and Bacillus subtilis (ATCC 6633) were obtained from National Chemical 
Laboratories (NCL), Pune. The culture and assay media were obtained from M/s Hi-Media Ltd., Mumbai. 
Rabbits of either sex were procured from central animal house of Rajah Muthiah Medical College and Hospital, 
Annamalai University.  
The plasma concentrations of Ampicillin and Norfloxacin were determined microbiologically (Filter 
paper disc – diffusion assay) using calibration curve, plotted between logarithm of spiked plasma concentration 
(X-axis) and diameter of zone of inhibition (Y-axis) to get a straight line response. The Plasma concentrations of 
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antibiotics were estimated from calibration curve by extrapolation of diameter of zone of inhibition 
(Pharmacopoeia of India, 1985, Prameela Rani 2004). The apparent elimination rate constant (Kel) for 
antibiotics was determined by non-linear regression analysis of the plasma concentration versus time data of the 
terminal phase (Gibaldi, 2005). Elimination half-life (t½) of antibiotics was calculated from relationship t½ = 
0.693/ Kel, the area under curve (AUC) was calculated using the trapezoidal rule (Gibaldi, 2005). The 
significance between the respective treatment group were calculated by paired Student’s‘t’ test. 
 
Experimental Design 
 Ampicillin Trihydrate, Norfloxacin and Piperine were prepared as suspension in carboxy methyl 
cellulose (CMC) (1% w/v) using pestle and mortar for oral administration to rabbits. The suspensions were fed 
to the rabbits using a apparatus called mouth-gag.  4 groups of rabbits (6 rabbits per group) weighing 1.5 to 2 kg 
were housed at constant temperature (25º ± 1°C) and light (10hr) and dark (14 hr) cycle was maintained 
throughout the experimental period. All animals were maintained on diet and quantity of water as prescribed by 
central animal house, Rajah Muthiah Medical College and Hospital, Annamalai University. Each rabbit group 
was administered with antibiotic as per Table 1:.Experimental Design 
Table 1: Experimental Design 
 
Rabbit groups Drug Adjuvant 
I 
Ampicillin Trihydrate               
(Equivalent to 150mg of Ampicillin/ 
kg body weight) 
No adjuvant                        (control) 
II 
Ampicillin Trihydrate              
(Equivalent to150mg of Ampicillin/ 
kg body weight) 
Piperine                             (20mg/kg 
body weight) 
(Bano et.al 1991 Hiwale et.al 2002,)  
III Norfloxacin                         (150 mg/kg body weight) 
No adjuvant                        (control) 
IV 
Norfloxacin                          (150 
mg/kg body weight) 
Piperine                          (20mg/kg body 
weight) 
(Bano et.al 1991 Hiwale et.al 2002,) 
 
 After administration of antibiotics with and without Piperine, each rabbit was fed with 12ml water. 
Exactly 0.5ml of blood samples were collected from the ear veins of rabbits using sterile syringes at time 
intervals equal to 3 half-lives of antibiotics [ t½ of Ampicillin= 1-2hrs, t½av-1.5hrs.  t½ of Norfloxacin = 4hrs] 
(Sweetman, 2002) and then transferred to sterile eppendorf tubes (2ml capacity) containing 10µl sterile 
anticoagulant solution (10% w/v sodium citrate). Then the blood samples were centrifuged at 2000 rpm for 20 
mins to separate the plasma. The above procedure was approved by Institutional Animal Ethics Committee 
[IAEC, Registration No. 160/1999/CPCSEA], of Rajah Muthiah College and Hospital, Annamalai University. 
 
Results and Discussion 
 
 The plasma concentration versus time profile of Ampicillin administered with and without Piperine is 
given in Table-2 and depicted as a plot in Figure 1. The data fitted to a one-compartment model with first order 
kinetics and other pharmacokinetic parameters derived from these data are given in Table 3. From Table 3 
differences in pharmacokinetic parameters in rabbits administered with Ampicillin and Piperine are inferred. . 
There is greater increase (about 338%) in AUC of rabbits administered with Ampicillin and Piperine. This may 
be due to changes in permeability of gastrointestinal epithelial cells (Johri et al., 1992) and inhibition of 
enzymes involved in conversion of ampicillin to penicilloic acid brought about by Piperine (Atal et al., 1985, 
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Singh et al., 1986). (Ampicillin is partly metabolized and excreted as such (20-40%) in Urine) (Sweetman, 
2002).  
 
 
 
 
 
Table 2:   Effect of Piperine on plasma concentration of Ampicillin in rabbits. (Values 
expressed as mcg/ml are Mean ± S.D.)* 
 
Time (hrs) Ampicillin Ampicillin + Piperine 
0.0 0 0 
0.5 30.584 ± 0.38 35.481 ± 0.26 
1.0 44.668 ± 0.32 251.188 ± 0.27 
1.5 31.672 ± 0.49 188.364 ± 0.31 
2.0 26.607 ± 0.37 84.139 ± 0.31 
2.5 18.836 ± 0.38 66.834 ± 0.26 
3.0 17.782 ± 0.32 35.481 ± 0.27 
3.5 12.589 ± 0.31 33.496 ± 0.26 
4.0 12.589 ± 0.32 26.607 ± 0.27 
4.5 9.441 ± 0.26 26.607 ± 0.27 
 
*n = 6,   p<0.05 
 
 
Table 3: Pharmacokinetic parameters of Ampicillin alone and in combination with Piperine.  (Values expressed 
as mcg/ml are Mean ± S.D.)* 
 
Tmax Cmax t½ AUC 
Treatment 
  (hr) (mcg/ml) (hr) (mcg/ml/hr) 
Ampicillin (150mg/kg) po 1±0.31 44.6±0.27 1.3±0.46 103.7±0.52 
 Ampicillin (150mg/kg) + Piperine (20mg/kg)po 1.1±0.3 251.2±0.28 1.9±0.57 350.486±0.47 
 
*p<0.05 
 
 
Effect of Piperine on bioavailability of Norfloxacin 
  
 The plasma concentration versus time profile of Norfloxacin administered with and without Piperine is 
given in Table-4 and graphically presented in Figure 2. The data fitted one compartment model with first order 
kinetics and other pharmacokinetic parameters are given Table 5. There is increase (about 174.6%) in AUC and 
also in other pharmacokinetic parameters of rabbits administered with Norfloxacin and Piperine. The 
enhancement of bioavailability of Norfloxacin by Piperine is comparatively less than that of Ampicillin. The 
enhancement of bioavailability may be due to inhibition of enzymes responsible for metabolism of Norfloxacin 
in liver (Atal et al., 1985). Norfloxacin is metabolized in liver (Sweetman, 2002). 
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Figure 1: Effect of Piperine on bioavaialbility of Ampicillin
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Table 4: Effect of Piperine on plasma concentration of Norfloxacin in rabbits (Values 
expressed as mcg/ml are Mean ± S.D.)* 
Time (hrs) Norfloxacin Norfloxacin + Piperine 
0.0 0 0 
1.0 10.593 ± 0.26 14.125 ± 0.27  
2.0 7.079 ± 0.26 17.783 ± 0.32 
3.0 5.623  ± 0.32 14.963 ± 0.27 
4.0 5.011  ± 0.38 11.885 ± 0.32 
5.0 4.732  ± 0.26 10.592 ± 0.37 
6.0 3.981  ± 0.26 8.414 ± 0.25 
7.0 3.548  ± 0.21 8.414 ± 0.26  
8.0 3.349  ± 0.26 7.079 ± 0.26 
9.0 3.162  ± 0.27 7.079 ± 0.27  
10.0 2.512  ± 0.27 5.623 ± 0.27 
11.0 2.238  ± 0.26 5.011 ± 0.27 
12.0 1.778  ± 0.26 4.467 ± 0.27 
*n = 6,   p<0. 
 
Table 5: Pharmacokinetic parameters of Norfloxacin alone and in combination with Piperine.  
(Values expressed as mcg/ml are Mean ± S.D.)* 
Tmax Cmax t½ AUC Treatment 
  (hr) (mcg/ml) (hr) (mcg/ml/hr) 
 Norfloxacin (150mg/kg) po 3.1±0.32 11±0.26 1.75±0.38 63.976±0.51 
 Norfloxacin (150 mg/kg) + Piperine (20 mg/kg)po 3.2±0.31 16.1±0.27 2.97±0.38 111.695±0.54 
 
*p<0.05 
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Figure 2. Effect of Piperine on bioavailability of 
Norfloxacin
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Conclusion 
 
  It is concluded that co-administration of Piperine with Ampicillin and Norfloxacin improved their oral 
bioavailability which is also reflected in various pharmacokinetic parameters studied. Since Piperine is a natural 
product used by many in day today food preparation with less toxicological consequences, Piperine might prove 
to be useful as an adjuvant dosage preparation (oral) of these antibiotics and would cut down the frequency of 
administration and the related side effects. This may also bring down the cost of treatment of many infections, 
which require the use of the above antibiotics. However, in depth bioavailability studies are necessary with 
Piperine for the above antibiotics, on human volunteers to establish  such a claim in clinical medicine. 
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